Portfolio company
NitroMed
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops and manufactures a combination medicine for the treatment of heart failure in African-American patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CV Therapeutics
This biopharmaceutical company develops and commercialises small molecule drugs for patients with cardiovascular diseases, including chronic angina and myocardial perfusion imaging needs.
NanoPhoria
This company develops an inhalable nano-drug delivery platform and therapeutics for patients with heart failure and other cardiovascular diseases.
CINC
This company develops biopharmaceutical treatments for cardio-renal diseases, primarily for patients with hypertension and chronic kidney disease.
Cardurion Pharmaceuticals
This clinical-stage biotechnology company develops therapeutic drugs for patients with heart failure and other cardiovascular diseases.
NeuroTronik
This medical technology company develops neurostimulation systems for clinicians to treat patients suffering from acute heart failure.
Cardiac Success Ltd.
This company develops a transcatheter ventricular repair device to treat patients suffering from heart failure with reduced ejection fraction.
Brano Therapeutics
This company develops small-molecule inhibitors to treat heart failure and metabolic dysfunction for patients with cardiovascular diseases.
Actelion
This company develops and manufactures pharmaceutical drugs to treat orphan diseases such as pulmonary arterial hypertension for patients and healthcare providers globally.
